{"gene":"SLC6A11","run_date":"2026-06-10T07:46:34","timeline":{"discoveries":[{"year":2026,"finding":"Cryo-EM structures of full-length wild-type human GAT3 were solved in three states: bound to a selective inhibitor (inward-open conformation), bound to substrate GABA (inward-occluded conformation), and substrate-free (inward-open). The inhibitor binds within the intracellular permeation pathway between transmembrane helices 1, 2, 3, 6, 7, and 8. GABA recognition involves a cation-π interaction between GABA's γ-amino group and a phenylalanine residue in transmembrane helix 6. The structures reveal the ion coordination network and the molecular determinants for inhibitor selectivity.","method":"Cryo-electron microscopy (cryo-EM) structural determination of full-length wild-type human GAT3","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — cryo-EM structures at multiple functional states with substrate and inhibitor bound, revealing catalytic mechanism and inhibitor binding site; single study but multiple orthogonal structural states with mechanistic validation","pmids":["41611703"],"is_preprint":false},{"year":1994,"finding":"Human GAT3 was cloned and expressed, demonstrating high-affinity GABA transport (IC50 ~5 µM for (S)-SNAP-5114 inhibition). The transporter shows sigmoidal Na+ dependence (Hill coefficient ~1.65), indicating >1 Na+ ion per transport cycle, and hyperbolic Cl- dependence (Hill coefficient ~1.05, Km ~78 mM). Reduction in Cl- increases the apparent Km for GABA, suggesting Cl- interaction is an early step in the transport mechanism. β-alanine is both a substrate and competitive inhibitor.","method":"Stable expression in LLC-PK1 cells; radiolabeled GABA uptake assays; ion substitution experiments; pharmacological profiling","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro transport assays with ion substitution and kinetic analysis establishing transport mechanism; replicated in multiple cell expression systems across labs","pmids":["7935337"],"is_preprint":false},{"year":1994,"finding":"Cloning and expression of the human homologue of GAT3 confirmed it as a functional GABA transporter. (S)-SNAP-5114 was identified as a selective inhibitor with IC50 of 5 µM at GAT3, 21 µM at GAT2, and ≥100 µM at GAT1 and BGT1, establishing GAT3 as a pharmacologically distinct transporter subtype.","method":"Molecular cloning; heterologous expression; competitive uptake inhibition assays","journal":"Receptors & channels","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct cloning and functional expression with pharmacological characterization; (S)-SNAP-5114 selectivity replicated extensively across subsequent literature","pmids":["7874447"],"is_preprint":false},{"year":1998,"finding":"Sorting determinants for GAT3 to the apical surface of polarized MDCK epithelial cells reside in its C-terminal cytoplasmic tail. A 22-amino-acid C-terminal sequence of GAT2 directs basolateral sorting; when appended to GAT3's C terminus, it redirects GAT3 to the basolateral surface. Deletion of 32 amino acids from GAT3's C terminus causes mislocalization to both surfaces. Removal of the final three amino acids (THF) of GAT3 disrupts apical sorting, suggesting interaction with a PDZ domain-containing protein mediates apical targeting.","method":"Stable expression of deletion constructs and chimeric GAT2/GAT3 transporters in MDCK cells; immunofluorescence localization assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple deletion and chimeric constructs with defined localization readouts; replicated with multiple constructs establishing C-terminal PDZ-interacting motif (THF) as apical sorting signal","pmids":["9748227"],"is_preprint":false},{"year":1996,"finding":"GAT-3 immunoreactivity in adult rat cerebral cortex is localized exclusively to astrocytic processes (not neuronal cell bodies or axon terminals), including processes adjacent to both symmetric (GABAergic) and asymmetric synapses. Only some GAT-3-positive astrocytic processes are adjacent to GABAergic profiles, indicating GAT-3 mediates glial GABA uptake and may limit GABA spread beyond the synapse.","method":"Immunocytochemistry with affinity-purified antibodies; pre-embedding immunolabeling for GAT-3 combined with post-embedding immunogold labeling for GABA; electron microscopy","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — ultrastructural localization with dual-label electron microscopy; replicated across multiple studies and species","pmids":["8815906"],"is_preprint":false},{"year":1996,"finding":"In rat cerebellum, GAT1 immunoreactivity is predominantly in presynaptic terminals whereas GAT3 immunoreactivity is localized to glial processes, as shown by electron microscopy. This establishes distinct cellular compartmentalization: neuronal GABA uptake via GAT1 and glial GABA uptake via GAT3.","method":"Immunoblot and immunocytochemistry with subtype-specific antibodies; electron microscopy","journal":"Brain research. Molecular brain research","confidence":"High","confidence_rationale":"Tier 2 / Strong — electron microscopic ultrastructural localization replicated across multiple brain regions and species by independent labs","pmids":["8738166"],"is_preprint":false},{"year":2011,"finding":"TRPA1 channel-mediated Ca2+ influx in astrocytes regulates GABA transport by GAT-3. Decreased astrocyte resting Ca2+ caused by TRPA1 inhibition reduces GABA transport by GAT-3, elevating extracellular GABA and reducing inhibitory synapse efficacy in hippocampal interneurons. Thus, TRPA1-generated Ca2+ microdomains near the plasma membrane target GAT-3 function in astrocytes.","method":"Membrane-tethered genetically encoded calcium indicator (Lck-GCaMP3) imaging; pharmacological blockade of TRPA1 and GAT-3 (SNAP-5114); electrophysiology in brain slices","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (Ca2+ imaging, pharmacology, electrophysiology) in both cultures and brain slices establishing Ca2+-GAT-3 mechanistic link","pmids":["22158513"],"is_preprint":false},{"year":2013,"finding":"In wild-type mouse striatum, GAT-3 operates in a releasing (reverse transport) mode, contributing to tonic GABAA receptor-mediated inhibition in striatal output neurons. In Huntington's disease mouse models (Z_Q175_KI and R6/2), this non-synaptic GABA release through GAT-3 is lost, reducing tonic inhibition. Astrocyte depolarization facilitates GABA release via GAT-3.","method":"Whole-cell patch-clamp recordings in acute brain slices; pharmacological blockade of GAT-3 with SNAP-5114; TTX application to separate synaptic from non-synaptic components","journal":"Frontiers in neural circuits","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — electrophysiology with selective GAT-3 blocker in multiple HD mouse models; single lab, two HD models support the finding","pmids":["24324407"],"is_preprint":false},{"year":2018,"finding":"In dopamine-depleted Parkinsonian rodents, glial GAT-3 transporters are downregulated in the external globus pallidus while neuronal GAT-1 function remains normal, leading to elevated extracellular GABA and persistent GABAergic tonic inhibition in GP neurons. In vivo GAT-3 blockade in control rodents impairs motor coordination, directly linking GAT-3 to basal ganglia motor control.","method":"Western blot for GAT-3 protein; whole-cell patch-clamp in brain slices; in vivo pharmacological blockade; dopamine depletion rodent models","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (Western blot, electrophysiology, in vivo behavior) in single lab using established PD models","pmids":["29742425"],"is_preprint":false},{"year":2016,"finding":"Neuroinflammation induced by hyperammonemia increases membrane expression of GAT-3 in activated astrocytes of the cerebellum, which increases extracellular GABA and impairs motor coordination and learning. Sulforaphane, by promoting M2 microglial polarization, reduces astrocyte activation and normalizes GAT-3 membrane expression and extracellular GABA levels.","method":"Western blot for GAT-3 membrane expression; immunohistochemistry; microdialysis for extracellular GABA; behavioral testing (Y maze, beam walking); sulforaphane treatment in hyperammonemic rats","journal":"Journal of neuroinflammation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (Western blot, microdialysis, behavior) in a single lab; neuroinflammation-GAT-3 membrane trafficking link established","pmids":["27090509"],"is_preprint":false},{"year":2022,"finding":"Down-regulation of GAT-3 in thalamic astrocytes is sufficient to produce cellular and circuit hyperexcitability, enhanced seizure risk, and cortical rhythm disruptions similar to those seen after cortical injury in mice. Enhancing GAT-3 expression specifically in thalamic astrocytes prevented these deficits and was protective against chemoconvulsant-induced seizures and mortality in a traumatic brain injury model.","method":"Viral vector-mediated GAT-3 knockdown and overexpression in thalamic astrocytes; EEG recording; seizure threshold testing; mouse models of cortical injury and TBI","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — bidirectional genetic manipulation (knockdown and rescue) in astrocyte-specific manner with multiple circuit and behavioral readouts in vivo; multiple injury models","pmids":["35857628"],"is_preprint":false},{"year":2005,"finding":"GAT-3 transporter blockade with SNAP-5114 in rat neocortical slices increases the amplitude of evoked GABAA responses and increases frequency and amplitude of spontaneous IPSCs in an action potential-dependent manner. This demonstrates that GAT-3 normally reduces ambient GABA levels, possibly by mediating carrier-mediated GABA release, and regulates inhibitory interneuron output.","method":"In vitro neocortical slice electrophysiology; pharmacological blockade of GAT-3 with SNAP-5114; TTX to test action potential dependence","journal":"Journal of neurophysiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — selective pharmacology with TTX controls establishing action potential-dependent mechanism; single lab","pmids":["16135550"],"is_preprint":false},{"year":2011,"finding":"In the rat globus pallidus, GAT-1 is localized preferentially to unmyelinated axons while GAT-3 is almost exclusively in glial processes. GAT-3 blockade (SNAP-5114) increases amplitude and prolongs decay time of evoked IPSCs from striatal stimulation, while GAT-1 blockade prolongs decay time only. Combined blockade has additive effects. High concentrations of both blockers induce GABAA receptor-mediated tonic currents, demonstrating complementary roles of the two transporters in regulating phasic and tonic inhibition.","method":"Electron microscopic immunocytochemistry; whole-cell patch-clamp in GP slices; pharmacological blockade with SKF89976A (GAT-1) and SNAP-5114 (GAT-3)","journal":"The European journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ultrastructural localization combined with functional electrophysiology with selective blockers; single lab","pmids":["21410779"],"is_preprint":false},{"year":2021,"finding":"In the ventral pallidum, GAT-3 is upregulated in astrocytes during extinction of heroin seeking but not after mere withdrawal or extinction of sucrose seeking. Knockdown of GAT-3 with a vivo-morpholino restored heroin seeking in the extinguished context and disrupted extinction. This establishes that astrocytic GAT-3 upregulation is a necessary mechanism for extinction of drug seeking.","method":"Confocal microscopy with membrane-bound fluorescent labeling of astrocytes; Western blot for GAT-3; vivo-morpholino knockdown; heroin self-administration and extinction behavioral paradigm","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function knockdown with specific behavioral readout (heroin seeking) combined with expression quantification; single lab","pmids":["34642457"],"is_preprint":false},{"year":2015,"finding":"Glutamate activates ionotropic glutamate receptors on avian Müller glial cells to decrease GAT-3 plasma membrane levels (shown by surface biotinylation), reducing GABA uptake capacity by ~50%. This effect is not mediated by PKC or PKA signaling pathways. Conditioned media from retinal neurons also decreases GABA uptake in a glutamate receptor-dependent manner.","method":"Surface biotinylation assay; [3H]GABA uptake assay; pharmacological receptor blockade; conditioned media experiments","journal":"Neurochemistry international","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — surface biotinylation directly demonstrates membrane trafficking of GAT-3 regulated by glutamate receptor signaling; two complementary methods","pmids":["25700791"],"is_preprint":false},{"year":2017,"finding":"GAT3 protein levels are decreased in peri-infarct tissue from 6 hours to 42 days post-stroke in mice. The GAT3 substrate L-isoserine, administered into the infarct, increased GAT3 expression in peri-infarct regions and improved motor recovery in a concentration-dependent manner without affecting infarct volume, demonstrating that a GAT3 substrate can upregulate GAT3 surface expression as a substrate-induced trafficking mechanism.","method":"Photothrombotic stroke mouse model; Western blot for GAT3 protein; intracranial L-isoserine infusion; behavioral assessment (grid-walking, cylinder tasks); immunohistochemistry","journal":"Journal of cerebral blood flow and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Western blot expression plus in vivo functional rescue experiment; single lab; substrate-induced trafficking mechanism proposed and supported by behavioral outcomes","pmids":["29160736"],"is_preprint":false},{"year":2024,"finding":"Activation of GAT-3 in dentate gyrus astrocytes triggers an increase in intracellular Ca2+ via the reverse Na+/Ca2+ exchanger. GAT-3 inhibition (SNAP-5114) impedes GABA-induced elevation of astrocytic Ca2+, curtailing subsequent enhancement of synaptic transmission. Endogenously released GABA from interneurons modulates synaptic transmission through GAT-3, and GAT-3 enhances excitatory transmission via presynaptic GluN2B-containing NMDARs. In vivo GAT-3 inhibition impairs contextual fear memory consolidation.","method":"Whole-cell patch-clamp; optogenetics; immunohistochemistry; behavioral assays (contextual fear conditioning); Ca2+ chelation experiments","journal":"Glia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (electrophysiology, optogenetics, behavior) in single lab establishing Ca2+-dependent GAT-3 signaling mechanism","pmids":["39573851"],"is_preprint":false},{"year":2023,"finding":"In developing somatosensory cortex of GAD67-GFP haplodeficient mice, GAT-3 operates in reverse (releasing) mode to provide ambient GABA for tonic activation of presynaptic and postsynaptic GABA-B receptors, restricting neuronal excitability. Blockade of GAT-3 (SNAP-5114) reproduced the effects of GABA-B receptor blockade (CGP55845), demonstrating that GAT-3-mediated reverse transport is the primary source of ambient GABA activating GABA-B receptors in this context.","method":"Whole-cell patch-clamp in cortical slices (P14-P21); multi-electrode array recordings; pharmacological blockade of GAT-3 and GABA-B receptors","journal":"Frontiers in synaptic neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — electrophysiology with pharmacological tools; GABA-B blockade mimicked by GAT-3 blockade; single lab","pmids":["37325697"],"is_preprint":false},{"year":2025,"finding":"Haploinsufficiency of SLC6A11 (GAT3), as modeled in HEK293T cells, results in reduced GAT3 protein expression and reduced GABA uptake, comparable in magnitude to known SLC6A1 missense variants. This establishes that one functional allele of SLC6A11 is insufficient for normal GABA transport capacity. 4-phenylbutyrate (PBA) treatment improved GABA uptake in haploinsufficient models and reduced epileptiform discharges in patients.","method":"[3H]GABA uptake assays in HEK293T cells; Western blotting; EEG recordings in patients; clinical phenotyping","journal":"Epilepsy research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct functional assay (GABA uptake) and Western blot in cell model plus patient EEG; single study combining cell and clinical data","pmids":["39923323"],"is_preprint":false},{"year":2025,"finding":"Proteochemometric modeling identified amino acid Q299 (in GAT3, corresponding to L300/Q299/L294/L314 in GAT1/BGT1/GAT2/GAT3) as a key residue for ligand binding and subtype selectivity of GAT3 relative to the other GABA transporter subtypes.","method":"Proteochemometric modeling (partial least squares, random forest) using dataset of 323 compounds with bioactivity data across four GABA transporter subtypes; analysis of protein descriptor importance","journal":"bioRxiv","confidence":"Low","confidence_rationale":"Tier 4 / Weak — computational prediction only, no experimental mutagenesis or structural validation of Q299 role performed in this study","pmids":[],"is_preprint":true},{"year":2025,"finding":"Functionally validated SLC6A11 variants (identified in patients with genetic generalized epilepsy) show reduced GAT3 GABA uptake activity, and the degree of activity reduction is linked to epilepsy severity, establishing a quantitative loss-of-function mechanism for SLC6A11 variants in epilepsy.","method":"Functional GAT3 uptake assays for SLC6A11 variants; cohort screening of 708 epilepsy patients; correlation of functional activity with clinical severity","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct functional uptake assays for multiple variants in patient cohort; preprint, single study","pmids":[],"is_preprint":true},{"year":2024,"finding":"Genetic ablation of GAT-3 (Gat3 CRISPR knockout) in astrocytes of the mouse visual cortex increases spontaneous and visually driven neuronal response magnitudes and trial-to-trial variability, and impairs population-level stimulus encoding, demonstrating that astrocytic GAT-3-mediated GABA clearance is required for accurate sensory information encoding.","method":"Multiplexed CRISPR/Cas9 Gat3 knockout in mouse visual cortex; in vivo two-photon calcium imaging; population neuronal response analysis","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo genetic loss-of-function with defined circuit readout; preprint, single lab","pmids":[],"is_preprint":true},{"year":2026,"finding":"GAT-3 inhibition with SNAP-5114 in the dorsal hippocampus impairs spatial memory consolidation (but not acquisition) and memory expression. This consolidation deficit is associated with reduced hippocampal protein synthesis (confirmed by puromycin incorporation assay). The memory deficit is rescued by prior open field exposure or proteasome inhibition but not by broader GABA transporter inhibition (nipecotic acid did not affect reconsolidation in the same way), indicating GAT-3 specifically modulates consolidation through protein synthesis mechanisms.","method":"Pharmacological GAT-3 inhibition (SNAP-5114) by stereotaxic injection; spatial object recognition task; puromycin incorporation assay for protein synthesis; behavioral rescue experiments","journal":"Communications biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct in vivo GAT-3 blockade with protein synthesis assay linking GAT-3 function to consolidation mechanism; single lab; published 2026","pmids":["42086667"],"is_preprint":false},{"year":2025,"finding":"In a C6 glioma model, GAT3 interacts with PMCA4 Ca2+ transporter and calmodulin within lipid raft microdomains. GAT3 knockdown alters resting Ca2+ and Ca2+ accumulation in lipid rafts following GABA stimulation, impairing glioma cell migration and invasion. Long-term GABA stimulation disrupts the PMCA4/GAT3 complex and induces GAT3- and CaMKII-dependent CREB phosphorylation at Ser133, controlling glioma invasiveness.","method":"Co-immunoprecipitation; lipid raft fractionation; Ca2+ imaging; GAT3 knockdown; glioma migration/invasion assays; Western blot for pCREB","journal":"Cell calcium","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP/pulldown in glioma cell model; single lab; functional linkage to CaMKII/CREB is mechanistically novel but based on single study with limited validation","pmids":["40580687"],"is_preprint":false}],"current_model":"SLC6A11/GAT3 is an astrocyte-localized, Na+- and Cl--dependent high-affinity GABA transporter (requiring >1 Na+ per cycle) whose C-terminal THF motif mediates PDZ-dependent apical membrane targeting; cryo-EM structures reveal substrate GABA bound in an inward-occluded state via a cation-π interaction with TM6 phenylalanine and selective inhibitors trapped in an inward-open state within the intracellular permeation pathway; beyond canonical GABA reuptake, GAT3 can operate in reverse (releasing) mode to provide ambient GABA for tonic GABA-B/GABA-A receptor activation, and its membrane expression is dynamically regulated by astrocyte Ca2+ (via TRPA1), neuroinflammation, and glutamate receptor signaling, with thalamic and pallidal astrocytic GAT3 activity being required for normal circuit excitability, motor control, memory consolidation, and protection against seizures after brain injury."},"narrative":{"mechanistic_narrative":"SLC6A11 (GAT3) is an astrocyte-localized, Na+- and Cl--dependent high-affinity GABA transporter that mediates glial GABA clearance and thereby sets ambient GABA tone to control neural circuit excitability [PMID:7935337, PMID:8815906, PMID:8738166]. Transport requires more than one Na+ ion per cycle (sigmoidal Na+ dependence, Hill coefficient ~1.65) and a Cl- co-substrate whose binding precedes GABA recognition, and the transporter is pharmacologically distinguished from other GABA transporter subtypes by the selective inhibitor (S)-SNAP-5114 [PMID:7935337, PMID:7874447]. Cryo-EM structures of the full-length human protein captured inhibitor-bound (inward-open), GABA-bound (inward-occluded), and substrate-free states, defining the ion-coordination network, a cation-π interaction between GABA's γ-amino group and a TM6 phenylalanine, and an intracellular inhibitor-binding pocket lined by TM1, 2, 3, 6, 7, and 8 [PMID:41611703]. Surface delivery is directed by the C-terminal cytoplasmic tail, whose terminal THF motif mediates PDZ-dependent apical targeting [PMID:9748227]. GAT3 membrane abundance is dynamically regulated: astrocyte Ca2+ entering through TRPA1 channels supports transport activity, while glutamate-receptor signaling, neuroinflammation, and substrate exposure adjust surface levels [PMID:22158513, PMID:25700791, PMID:27090509, PMID:29160736]. Beyond reuptake, GAT3 can run in reverse to release GABA that drives tonic GABA-A and GABA-B receptor activation [PMID:24324407, PMID:37325697, PMID:16135550]. Astrocytic GAT3 activity in the thalamus, pallidum, hippocampus, and cortex is required for normal circuit excitability, motor control, sensory encoding, and memory consolidation, and its enhancement protects against seizures after brain injury [PMID:35857628, PMID:29742425, PMID:39573851, PMID:42086667]. Functionally validated loss-of-function SLC6A11 variants and haploinsufficiency reduce GABA uptake and cause genetic generalized epilepsy [PMID:39923323].","teleology":[{"year":1994,"claim":"Establishing GAT3 as a functional, ion-coupled GABA transporter answered what activity the cloned gene product performs and how its transport cycle is energized.","evidence":"Heterologous expression in LLC-PK1 cells with radiolabeled GABA uptake, ion-substitution, and kinetic analysis","pmids":["7935337"],"confidence":"High","gaps":["Stoichiometry inferred from Hill coefficients rather than direct ion flux measurement","Did not address native cellular context or trafficking"]},{"year":1994,"claim":"Identifying (S)-SNAP-5114 as a GAT3-preferring inhibitor distinguished GAT3 pharmacologically from GAT1, GAT2, and BGT1, providing the tool used in nearly all subsequent functional dissection.","evidence":"Molecular cloning, heterologous expression, and competitive uptake inhibition across four GABA transporter subtypes","pmids":["7874447"],"confidence":"High","gaps":["Molecular basis of subtype selectivity not resolved","Did not define inhibitor binding site"]},{"year":1996,"claim":"Ultrastructural localization established that GAT3, unlike neuronal GAT1, resides in astrocytic processes, defining it as the glial arm of GABA uptake.","evidence":"Dual-label immunogold electron microscopy in rat cortex and cerebellum with subtype-specific antibodies","pmids":["8815906","8738166"],"confidence":"High","gaps":["Did not establish functional consequence of glial localization","Mechanism restricting GABA spread inferred from anatomy"]},{"year":1998,"claim":"Mapping the apical-sorting signal to the C-terminal THF motif explained how GAT3 is targeted to a specific membrane domain and implicated a PDZ-domain partner.","evidence":"Deletion and chimeric GAT2/GAT3 constructs in polarized MDCK cells with immunofluorescence localization","pmids":["9748227"],"confidence":"High","gaps":["The specific PDZ-domain protein was not identified","Sorting studied in epithelial, not astrocytic, cells"]},{"year":2005,"claim":"Showing that GAT3 blockade increases ambient GABA and IPSCs established that GAT3 actively limits extracellular GABA and shapes inhibitory output.","evidence":"Neocortical slice electrophysiology with SNAP-5114 and TTX action-potential controls","pmids":["16135550"],"confidence":"Medium","gaps":["Did not distinguish uptake vs. carrier-mediated release directly","Single brain region, single lab"]},{"year":2011,"claim":"Linking astrocyte TRPA1-mediated Ca2+ microdomains to GAT3 function revealed that transport is dynamically gated by local astrocytic calcium.","evidence":"Membrane-tethered GCaMP3 imaging, TRPA1/GAT3 pharmacology, and slice electrophysiology","pmids":["22158513"],"confidence":"High","gaps":["Molecular coupling between Ca2+ and transporter activity unresolved","Whether Ca2+ alters trafficking or intrinsic transport rate not separated"]},{"year":2011,"claim":"Demonstrating complementary phasic/tonic roles of glial GAT3 and axonal GAT1 in globus pallidus clarified the division of labor between the two transporters.","evidence":"Electron microscopic immunocytochemistry plus patch-clamp with selective GAT1/GAT3 blockers","pmids":["21410779"],"confidence":"Medium","gaps":["Additive vs. interactive effects only inferred pharmacologically","Single lab"]},{"year":2013,"claim":"Identifying a reverse (releasing) mode of GAT3 contributing to tonic inhibition, lost in Huntington's models, extended GAT3's role beyond reuptake to active GABA supply.","evidence":"Patch-clamp in striatal slices with SNAP-5114 and TTX in two HD mouse models","pmids":["24324407"],"confidence":"Medium","gaps":["Trigger and directionality control of reverse transport not defined","Single lab"]},{"year":2015,"claim":"Showing glutamate-receptor signaling reduces GAT3 surface levels identified neurotransmitter-driven trafficking as a regulator of glial GABA uptake capacity.","evidence":"Surface biotinylation and [3H]GABA uptake with receptor blockade in avian Muller glia","pmids":["25700791"],"confidence":"Medium","gaps":["Signaling pathway downstream of glutamate receptors unknown (not PKC/PKA)","Avian retinal glia model"]},{"year":2016,"claim":"Demonstrating that neuroinflammation increases GAT3 membrane expression and elevates extracellular GABA tied transporter trafficking to disease-relevant behavioral deficits.","evidence":"Membrane Western blot, microdialysis, and behavior in hyperammonemic rats with sulforaphane rescue","pmids":["27090509"],"confidence":"Medium","gaps":["Direct astrocyte signaling mediating increased surface GAT3 not defined","Single lab"]},{"year":2017,"claim":"Showing a GAT3 substrate (L-isoserine) can upregulate GAT3 and improve post-stroke recovery established substrate-induced trafficking as a tractable mechanism.","evidence":"Photothrombotic stroke model, Western blot, intracranial substrate infusion, and motor behavior","pmids":["29160736"],"confidence":"Medium","gaps":["Trafficking mechanism inferred from expression changes, not directly imaged","Single lab"]},{"year":2018,"claim":"Linking pallidal GAT3 downregulation to elevated GABA tone and motor impairment in Parkinsonian models connected GAT3 directly to basal ganglia motor control.","evidence":"Western blot, slice patch-clamp, and in vivo GAT3 blockade in dopamine-depleted rodents","pmids":["29742425"],"confidence":"Medium","gaps":["Cause of GAT3 downregulation after dopamine depletion unknown","Single lab"]},{"year":2022,"claim":"Bidirectional astrocyte-specific manipulation showed thalamic GAT3 level is causally sufficient to set circuit excitability and seizure risk, nominating it as a therapeutic target.","evidence":"Viral GAT3 knockdown/overexpression in thalamic astrocytes with EEG and seizure assays in injury models","pmids":["35857628"],"confidence":"High","gaps":["Whether thalamic mechanism generalizes to other epileptogenic circuits unclear","Downstream receptor targets of altered GABA tone not mapped here"]},{"year":2024,"claim":"Identifying GAT3-driven Ca2+ entry via reverse Na+/Ca2+ exchange and its requirement for fear memory consolidation revealed a signaling output of GAT3 beyond GABA clearance.","evidence":"Patch-clamp, optogenetics, Ca2+ chelation, and contextual fear conditioning in dentate gyrus","pmids":["39573851"],"confidence":"Medium","gaps":["Link between astrocytic Ca2+ and presynaptic GluN2B-NMDAR enhancement mechanistically incomplete","Single lab"]},{"year":2023,"claim":"Showing GAT3 reverse transport is the primary source of ambient GABA activating GABA-B receptors in developing cortex defined a developmental excitability-restraining role.","evidence":"Cortical slice patch-clamp and multi-electrode arrays with GAT3 and GABA-B blockade in GAD67-GFP mice","pmids":["37325697"],"confidence":"Medium","gaps":["Developmental specificity vs. adult function not addressed","Single lab"]},{"year":2025,"claim":"Functional analysis of patient variants and modeled haploinsufficiency established a quantitative loss-of-function mechanism connecting reduced GAT3 GABA uptake to genetic generalized epilepsy.","evidence":"GABA uptake assays for SLC6A11 variants in HEK293T cells, cohort screening, EEG, and 4-PBA rescue","pmids":["39923323"],"confidence":"Medium","gaps":["Causal proof in vivo from patient variants not yet shown","Genotype-phenotype severity correlation from preprint cohort (PMID-less) needs peer review"]},{"year":2026,"claim":"Cryo-EM of full-length human GAT3 in multiple states defined the atomic basis of GABA recognition, ion coordination, and inhibitor selectivity, anchoring decades of functional pharmacology to structure.","evidence":"Cryo-EM structures of wild-type human GAT3 bound to inhibitor, GABA, and substrate-free","pmids":["41611703"],"confidence":"High","gaps":["Outward-facing and fully outward-open states not captured","Conformational dynamics of transport cycle inferred from static states"]},{"year":2026,"claim":"Showing hippocampal GAT3 inhibition selectively impairs memory consolidation via reduced protein synthesis distinguished a consolidation-specific role from general GABA transport.","evidence":"Stereotaxic SNAP-5114 injection, spatial object recognition, puromycin incorporation, and rescue experiments","pmids":["42086667"],"confidence":"Medium","gaps":["Molecular path from GAT3 activity to protein synthesis not delineated","Single lab"]},{"year":null,"claim":"How GAT3 surface trafficking, reverse-transport directionality, and astrocytic Ca2+ signaling are molecularly coordinated across circuits, and the identity of its PDZ-domain sorting partner, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["PDZ partner mediating THF-dependent targeting not identified","Mechanism switching uptake vs. release mode undefined","Direct in vivo causation for human epilepsy variants outstanding"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[1,2,0,18]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[1,7,17]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,4,5,14]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[4,11,10,16]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[1,2]}],"complexes":[],"partners":[],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P48066","full_name":"Sodium- and chloride-dependent GABA transporter 3","aliases":["Solute carrier family 6 member 11"],"length_aa":632,"mass_kda":70.6,"function":"Mediates sodium- and chloride-dependent transport of gamma-aminobutyric acid (GABA) (PubMed:7874447). Can also mediate transport of beta-alanine and to a lower extent that of taurine and hypotaurine (By similarity)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P48066/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SLC6A11","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SLC6A11","total_profiled":1310},"omim":[{"mim_id":"615097","title":"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GABA), MEMBER 13; SLC6A13","url":"https://www.omim.org/entry/615097"},{"mim_id":"608768","title":"SPINOCEREBELLAR ATAXIA 8; SCA8","url":"https://www.omim.org/entry/608768"},{"mim_id":"607952","title":"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GABA), MEMBER 11; SLC6A11","url":"https://www.omim.org/entry/607952"},{"mim_id":"603680","title":"ATAXIN 8 OPPOSITE STRAND; ATXN8OS","url":"https://www.omim.org/entry/603680"},{"mim_id":"137165","title":"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GABA), MEMBER 1; SLC6A1","url":"https://www.omim.org/entry/137165"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Nucleoplasm","reliability":"Uncertain"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":77.7}],"url":"https://www.proteinatlas.org/search/SLC6A11"},"hgnc":{"alias_symbol":["GAT3"],"prev_symbol":[]},"alphafold":{"accession":"P48066","domains":[{"cath_id":"1.20.1740.10","chopping":"59-186_197-576","consensus_level":"medium","plddt":94.4066,"start":59,"end":576}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P48066","model_url":"https://alphafold.ebi.ac.uk/files/AF-P48066-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P48066-F1-predicted_aligned_error_v6.png","plddt_mean":86.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SLC6A11","jax_strain_url":"https://www.jax.org/strain/search?query=SLC6A11"},"sequence":{"accession":"P48066","fasta_url":"https://rest.uniprot.org/uniprotkb/P48066.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P48066/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P48066"}},"corpus_meta":[{"pmid":"22158513","id":"PMC_22158513","title":"TRPA1 channels regulate astrocyte resting calcium and inhibitory synapse efficacy through GAT-3.","date":"2011","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22158513","citation_count":372,"is_preprint":false},{"pmid":"8815906","id":"PMC_8815906","title":"GAT-3, a high-affinity GABA plasma membrane transporter, is localized to astrocytic processes, and it is not confined to the vicinity of GABAergic synapses in the cerebral cortex.","date":"1996","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/8815906","citation_count":225,"is_preprint":false},{"pmid":"7854065","id":"PMC_7854065","title":"Production of specific antibodies against GABA transporter subtypes (GAT1, GAT2, GAT3) and their application to immunocytochemistry.","date":"1994","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/7854065","citation_count":115,"is_preprint":false},{"pmid":"8915826","id":"PMC_8915826","title":"Multiple gamma-Aminobutyric acid plasma membrane transporters (GAT-1, GAT-2, GAT-3) in the rat retina.","date":"1996","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/8915826","citation_count":99,"is_preprint":false},{"pmid":"27090509","id":"PMC_27090509","title":"Neuroinflammation increases GABAergic tone and impairs cognitive and motor function in hyperammonemia by increasing GAT-3 membrane expression. Reversal by sulforaphane by promoting M2 polarization of microglia.","date":"2016","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/27090509","citation_count":96,"is_preprint":false},{"pmid":"7874447","id":"PMC_7874447","title":"Cloning of the human homologue of the GABA transporter GAT-3 and identification of a novel inhibitor with selectivity for this site.","date":"1994","source":"Receptors & channels","url":"https://pubmed.ncbi.nlm.nih.gov/7874447","citation_count":94,"is_preprint":false},{"pmid":"24324407","id":"PMC_24324407","title":"Reduced tonic inhibition in striatal output neurons from Huntington mice due to loss of astrocytic GABA release through GAT-3.","date":"2013","source":"Frontiers in neural circuits","url":"https://pubmed.ncbi.nlm.nih.gov/24324407","citation_count":85,"is_preprint":false},{"pmid":"9748227","id":"PMC_9748227","title":"Identification of sorting determinants in the C-terminal cytoplasmic tails of the gamma-aminobutyric acid transporters GAT-2 and GAT-3.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9748227","citation_count":79,"is_preprint":false},{"pmid":"21847373","id":"PMC_21847373","title":"Localization and Function of GABA Transporters GAT-1 and GAT-3 in the Basal Ganglia.","date":"2011","source":"Frontiers in systems neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21847373","citation_count":65,"is_preprint":false},{"pmid":"8738166","id":"PMC_8738166","title":"Neuronal and glial localization of two GABA transporters (GAT1 and GAT3) in the rat cerebellum.","date":"1996","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/8738166","citation_count":61,"is_preprint":false},{"pmid":"16456667","id":"PMC_16456667","title":"GAT1 and GAT3 expression are differently localized in the human epileptogenic hippocampus.","date":"2006","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/16456667","citation_count":54,"is_preprint":false},{"pmid":"7935337","id":"PMC_7935337","title":"Stable expression of a neuronal gamma-aminobutyric acid transporter, GAT-3, in mammalian cells demonstrates unique pharmacological properties and ion dependence.","date":"1994","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/7935337","citation_count":52,"is_preprint":false},{"pmid":"29742425","id":"PMC_29742425","title":"GAT-3 Dysfunction Generates Tonic Inhibition in External Globus Pallidus Neurons in Parkinsonian Rodents.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29742425","citation_count":50,"is_preprint":false},{"pmid":"12694940","id":"PMC_12694940","title":"Postnatal development of high-affinity plasma membrane GABA transporters GAT-2 and GAT-3 in the rat cerebral cortex.","date":"2003","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/12694940","citation_count":50,"is_preprint":false},{"pmid":"12898208","id":"PMC_12898208","title":"Expression of GABA transporters, GAT-1 and GAT-3, in the cerebral cortex and thalamus of the rat during postnatal development.","date":"2003","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/12898208","citation_count":49,"is_preprint":false},{"pmid":"16135550","id":"PMC_16135550","title":"GAT-3 transporters regulate inhibition in the neocortex.","date":"2005","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/16135550","citation_count":45,"is_preprint":false},{"pmid":"11323124","id":"PMC_11323124","title":"Increased expression of gamma-aminobutyric acid transporters GAT-1 and GAT-3 in the spinal trigeminal nucleus after facial carrageenan injections.","date":"2001","source":"Pain","url":"https://pubmed.ncbi.nlm.nih.gov/11323124","citation_count":43,"is_preprint":false},{"pmid":"35857628","id":"PMC_35857628","title":"Enhancing GAT-3 in thalamic astrocytes promotes resilience to brain injury in rodents.","date":"2022","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35857628","citation_count":38,"is_preprint":false},{"pmid":"16766089","id":"PMC_16766089","title":"New highly potent GABA uptake inhibitors selective for GAT-1 and GAT-3 derived from (R)- and (S)-proline and homologous pyrrolidine-2-alkanoic acids.","date":"2006","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16766089","citation_count":35,"is_preprint":false},{"pmid":"15248296","id":"PMC_15248296","title":"Changes in GABA transporters in the rat hippocampus after kainate-induced neuronal injury: decrease in GAT-1 and GAT-3 but upregulation of betaine/GABA transporter BGT-1.","date":"2004","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/15248296","citation_count":35,"is_preprint":false},{"pmid":"25256099","id":"PMC_25256099","title":"3p25.3 microdeletion of GABA transporters SLC6A1 and SLC6A11 results in intellectual disability, epilepsy and stereotypic behavior.","date":"2014","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/25256099","citation_count":33,"is_preprint":false},{"pmid":"15821932","id":"PMC_15821932","title":"Differential expression of the GABA transporters GAT-1 and GAT-3 in brains of rats, cats, monkeys and humans.","date":"2005","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/15821932","citation_count":32,"is_preprint":false},{"pmid":"21410779","id":"PMC_21410779","title":"Differential localization and function of GABA transporters, GAT-1 and GAT-3, in the rat globus pallidus.","date":"2011","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21410779","citation_count":32,"is_preprint":false},{"pmid":"29370841","id":"PMC_29370841","title":"Expression of functional inhibitory neurotransmitter transporters GlyT1, GAT-1, and GAT-3 by astrocytes of inferior colliculus and hippocampus.","date":"2018","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/29370841","citation_count":31,"is_preprint":false},{"pmid":"26154082","id":"PMC_26154082","title":"Identification of the First Highly Subtype-Selective Inhibitor of Human GABA Transporter GAT3.","date":"2015","source":"ACS chemical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26154082","citation_count":30,"is_preprint":false},{"pmid":"34642457","id":"PMC_34642457","title":"Astrocytes in the ventral pallidum extinguish heroin seeking through GAT-3 upregulation and morphological plasticity at D1-MSN terminals.","date":"2021","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/34642457","citation_count":29,"is_preprint":false},{"pmid":"19288275","id":"PMC_19288275","title":"Reduced expression of GABA transporter GAT3 in helpless rats, an animal model of depression.","date":"2009","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/19288275","citation_count":27,"is_preprint":false},{"pmid":"9838150","id":"PMC_9838150","title":"Developmental expression of gamma-aminobutyric acid transporters (GAT-1 and GAT-3) in the rat cerebellum: evidence for a transient presence of GAT-1 in Purkinje cells.","date":"1998","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/9838150","citation_count":26,"is_preprint":false},{"pmid":"33527681","id":"PMC_33527681","title":"Baclofen decreases compulsive alcohol drinking in rats characterized by reduced levels of GAT-3 in the central amygdala.","date":"2021","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/33527681","citation_count":25,"is_preprint":false},{"pmid":"13678673","id":"PMC_13678673","title":"Transient focal ischemia triggers neuronal expression of GAT-3 in the rat perilesional cortex.","date":"2003","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/13678673","citation_count":25,"is_preprint":false},{"pmid":"10348670","id":"PMC_10348670","title":"Developmental expression of the neurotransmitter transporter GAT3.","date":"1999","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/10348670","citation_count":23,"is_preprint":false},{"pmid":"33710537","id":"PMC_33710537","title":"Downregulation of GABA Transporter 3 (GAT3) is Associated with Deficient Oxidative GABA Metabolism in Human Induced Pluripotent Stem Cell-Derived Astrocytes in Alzheimer's Disease.","date":"2021","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/33710537","citation_count":23,"is_preprint":false},{"pmid":"29160736","id":"PMC_29160736","title":"GAT3 selective substrate l-isoserine upregulates GAT3 expression and increases functional recovery after a focal ischemic stroke in mice.","date":"2017","source":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/29160736","citation_count":22,"is_preprint":false},{"pmid":"11283414","id":"PMC_11283414","title":"A light and electron microscopic study of the GABA transporter GAT-3 in the monkey basal ganglia and brainstem.","date":"2000","source":"Journal of neurocytology","url":"https://pubmed.ncbi.nlm.nih.gov/11283414","citation_count":21,"is_preprint":false},{"pmid":"25103283","id":"PMC_25103283","title":"Functional analysis of the inhibitory neurotransmitter transporters GlyT1, GAT-1, and GAT-3 in astrocytes of the lateral superior olive.","date":"2014","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/25103283","citation_count":21,"is_preprint":false},{"pmid":"15923108","id":"PMC_15923108","title":"Neuronal localization of the GABA transporter GAT-3 in human cerebral cortex: a procedural artifact?","date":"2005","source":"Journal of chemical neuroanatomy","url":"https://pubmed.ncbi.nlm.nih.gov/15923108","citation_count":20,"is_preprint":false},{"pmid":"10406141","id":"PMC_10406141","title":"Expression of GABA transporter subtypes (GAT1, GAT3) in the adult rabbit retina.","date":"1999","source":"Acta ophthalmologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/10406141","citation_count":19,"is_preprint":false},{"pmid":"25700791","id":"PMC_25700791","title":"Functional plasticity of GAT-3 in avian Müller cells is regulated by neurons via a glutamatergic input.","date":"2015","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/25700791","citation_count":17,"is_preprint":false},{"pmid":"23795861","id":"PMC_23795861","title":"Gaba transporter SLC6A11 gene polymorphism associated with tardive dyskinesia.","date":"2013","source":"Nordic journal of psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/23795861","citation_count":16,"is_preprint":false},{"pmid":"32301730","id":"PMC_32301730","title":"GAT-1 (rs2697153) and GAT-3 (rs2272400) polymorphisms are associated with febrile seizures and temporal lobe epilepsy.","date":"2020","source":"Epileptic disorders : international epilepsy journal with videotape","url":"https://pubmed.ncbi.nlm.nih.gov/32301730","citation_count":14,"is_preprint":false},{"pmid":"21776001","id":"PMC_21776001","title":"Association of a synonymous GAT3 polymorphism with antiepileptic drug pharmacoresistance.","date":"2011","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21776001","citation_count":10,"is_preprint":false},{"pmid":"9479049","id":"PMC_9479049","title":"Increased expression of GABA transporters, GAT-1 and GAT-3, in the deafferented superior colliculus of the rat.","date":"1998","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/9479049","citation_count":10,"is_preprint":false},{"pmid":"10353341","id":"PMC_10353341","title":"Immunoreactivity for multiple GABA transporters (GAT-1, GAT-2, GAT-3) in the gerbil pineal gland.","date":"1999","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/10353341","citation_count":10,"is_preprint":false},{"pmid":"39923323","id":"PMC_39923323","title":"4-Phenylbutyrate restored GABA uptake, mitigated seizures in SLC6A1 and SLC6A11 microdeletions/3p- syndrome: From cellular models to human patients.","date":"2025","source":"Epilepsy research","url":"https://pubmed.ncbi.nlm.nih.gov/39923323","citation_count":9,"is_preprint":false},{"pmid":"11248347","id":"PMC_11248347","title":"Developmental changes in GABA transporter (GAT1 and GAT3) mRNA expressions in the rat olfactory bulb.","date":"2001","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/11248347","citation_count":9,"is_preprint":false},{"pmid":"10592344","id":"PMC_10592344","title":"Quantitation of GABA transporter 3 (GAT3) mRNA in rat brain by competitive RT-PCR.","date":"1999","source":"Brain research. Brain research protocols","url":"https://pubmed.ncbi.nlm.nih.gov/10592344","citation_count":7,"is_preprint":false},{"pmid":"10406142","id":"PMC_10406142","title":"Expression of GABA transporter subtypes (GAT1, GAT3) in the developing rabbit retina.","date":"1999","source":"Acta ophthalmologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/10406142","citation_count":6,"is_preprint":false},{"pmid":"37325697","id":"PMC_37325697","title":"Tonic activation of GABAB receptors via GAT-3 mediated GABA release reduces network activity in the developing somatosensory cortex in GAD67-GFP mice.","date":"2023","source":"Frontiers in synaptic neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/37325697","citation_count":6,"is_preprint":false},{"pmid":"39573851","id":"PMC_39573851","title":"Astrocytic GAT-3 Regulates Synaptic Transmission and Memory Formation in the Dentate Gyrus.","date":"2024","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/39573851","citation_count":5,"is_preprint":false},{"pmid":"23225341","id":"PMC_23225341","title":"Development and validation of an LC-ESI-MS/MS quantification method for a potential γ-aminobutyric acid transporter 3 (GAT3) marker and its application in preliminary MS binding assays.","date":"2012","source":"Biomedical chromatography : BMC","url":"https://pubmed.ncbi.nlm.nih.gov/23225341","citation_count":3,"is_preprint":false},{"pmid":"38369179","id":"PMC_38369179","title":"Manganese- and zinc-coordinated interaction of Schistosoma japonicum glutathione S-transferase with neurotransmitter transporters GlyT1 and GAT3 in vitro.","date":"2024","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/38369179","citation_count":2,"is_preprint":false},{"pmid":"28792706","id":"PMC_28792706","title":"Lack of Association between SLC6A11 Genetic Polymorphisms and Drug Resistant Epilepsy in Chinese Han Population.","date":"2017","source":"Clinical laboratory","url":"https://pubmed.ncbi.nlm.nih.gov/28792706","citation_count":2,"is_preprint":false},{"pmid":"41410815","id":"PMC_41410815","title":"Association of CYP3A4*1B and SLC6A11 Genetic Variants with Epilepsy Risk And Antiepileptic Drug Response in an Iraqi Population.","date":"2025","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/41410815","citation_count":0,"is_preprint":false},{"pmid":"40580687","id":"PMC_40580687","title":"GAT3-dependent regulation of glioma invasiveness via a lipid raft-associated PMCA4 Ca2+ transporter and a downstream CaMKII/CREB signaling - implications for compartmentalized signaling in glioma tumors.","date":"2025","source":"Cell calcium","url":"https://pubmed.ncbi.nlm.nih.gov/40580687","citation_count":0,"is_preprint":false},{"pmid":"41611703","id":"PMC_41611703","title":"Structural basis for selective inhibition of human GABA transporter GAT3.","date":"2026","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/41611703","citation_count":0,"is_preprint":false},{"pmid":"42086667","id":"PMC_42086667","title":"Hippocampal astrocytic GAT-3 blockade impairs protein synthesis and spatial memory dynamics.","date":"2026","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/42086667","citation_count":0,"is_preprint":false},{"pmid":"13129709","id":"PMC_13129709","title":"[Changes in GAT-3 and GABA-T mRNA expression of C6 glioma cells in response to a 2-week treatment with sodium valproate and withdrawal].","date":"2003","source":"Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA","url":"https://pubmed.ncbi.nlm.nih.gov/13129709","citation_count":0,"is_preprint":false},{"pmid":"41797906","id":"PMC_41797906","title":"Prelimbic cortex to zona incerta pathway mediates recognition memory recovery delay through down-regulating astrocytic GAT-3.","date":"2026","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/41797906","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.04.01.24316792","title":"Pathogenic ultra-rare variants in<i>SLC6A1, SLC6A11, GAD1 and GAD2</i>are new & recurrent GABAergic loci for GGE syndromes","date":"2025-04-04","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.01.24316792","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.08.13.607728","title":"Proteochemometric modeling strengthens the role of Q299 for GABA transporter subtype selectivity","date":"2024-08-16","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.13.607728","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.11.06.622321","title":"Astrocytic modulation of population encoding in mouse visual cortex via GABA transporter 3 revealed by multiplexed CRISPR/Cas9 gene editing","date":"2024-11-07","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.06.622321","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.11.17.24317299","title":"Associations between DNA methylation and cognitive function in early-stage hormone receptor-positive breast cancer patients","date":"2024-11-18","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.17.24317299","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":33173,"output_tokens":6659,"usd":0.099702,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15824,"output_tokens":5018,"usd":0.102285,"stage2_stop_reason":"end_turn"},"total_usd":0.201987,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2026,\n      \"finding\": \"Cryo-EM structures of full-length wild-type human GAT3 were solved in three states: bound to a selective inhibitor (inward-open conformation), bound to substrate GABA (inward-occluded conformation), and substrate-free (inward-open). The inhibitor binds within the intracellular permeation pathway between transmembrane helices 1, 2, 3, 6, 7, and 8. GABA recognition involves a cation-π interaction between GABA's γ-amino group and a phenylalanine residue in transmembrane helix 6. The structures reveal the ion coordination network and the molecular determinants for inhibitor selectivity.\",\n      \"method\": \"Cryo-electron microscopy (cryo-EM) structural determination of full-length wild-type human GAT3\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cryo-EM structures at multiple functional states with substrate and inhibitor bound, revealing catalytic mechanism and inhibitor binding site; single study but multiple orthogonal structural states with mechanistic validation\",\n      \"pmids\": [\"41611703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Human GAT3 was cloned and expressed, demonstrating high-affinity GABA transport (IC50 ~5 µM for (S)-SNAP-5114 inhibition). The transporter shows sigmoidal Na+ dependence (Hill coefficient ~1.65), indicating >1 Na+ ion per transport cycle, and hyperbolic Cl- dependence (Hill coefficient ~1.05, Km ~78 mM). Reduction in Cl- increases the apparent Km for GABA, suggesting Cl- interaction is an early step in the transport mechanism. β-alanine is both a substrate and competitive inhibitor.\",\n      \"method\": \"Stable expression in LLC-PK1 cells; radiolabeled GABA uptake assays; ion substitution experiments; pharmacological profiling\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro transport assays with ion substitution and kinetic analysis establishing transport mechanism; replicated in multiple cell expression systems across labs\",\n      \"pmids\": [\"7935337\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Cloning and expression of the human homologue of GAT3 confirmed it as a functional GABA transporter. (S)-SNAP-5114 was identified as a selective inhibitor with IC50 of 5 µM at GAT3, 21 µM at GAT2, and ≥100 µM at GAT1 and BGT1, establishing GAT3 as a pharmacologically distinct transporter subtype.\",\n      \"method\": \"Molecular cloning; heterologous expression; competitive uptake inhibition assays\",\n      \"journal\": \"Receptors & channels\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct cloning and functional expression with pharmacological characterization; (S)-SNAP-5114 selectivity replicated extensively across subsequent literature\",\n      \"pmids\": [\"7874447\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Sorting determinants for GAT3 to the apical surface of polarized MDCK epithelial cells reside in its C-terminal cytoplasmic tail. A 22-amino-acid C-terminal sequence of GAT2 directs basolateral sorting; when appended to GAT3's C terminus, it redirects GAT3 to the basolateral surface. Deletion of 32 amino acids from GAT3's C terminus causes mislocalization to both surfaces. Removal of the final three amino acids (THF) of GAT3 disrupts apical sorting, suggesting interaction with a PDZ domain-containing protein mediates apical targeting.\",\n      \"method\": \"Stable expression of deletion constructs and chimeric GAT2/GAT3 transporters in MDCK cells; immunofluorescence localization assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple deletion and chimeric constructs with defined localization readouts; replicated with multiple constructs establishing C-terminal PDZ-interacting motif (THF) as apical sorting signal\",\n      \"pmids\": [\"9748227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"GAT-3 immunoreactivity in adult rat cerebral cortex is localized exclusively to astrocytic processes (not neuronal cell bodies or axon terminals), including processes adjacent to both symmetric (GABAergic) and asymmetric synapses. Only some GAT-3-positive astrocytic processes are adjacent to GABAergic profiles, indicating GAT-3 mediates glial GABA uptake and may limit GABA spread beyond the synapse.\",\n      \"method\": \"Immunocytochemistry with affinity-purified antibodies; pre-embedding immunolabeling for GAT-3 combined with post-embedding immunogold labeling for GABA; electron microscopy\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ultrastructural localization with dual-label electron microscopy; replicated across multiple studies and species\",\n      \"pmids\": [\"8815906\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"In rat cerebellum, GAT1 immunoreactivity is predominantly in presynaptic terminals whereas GAT3 immunoreactivity is localized to glial processes, as shown by electron microscopy. This establishes distinct cellular compartmentalization: neuronal GABA uptake via GAT1 and glial GABA uptake via GAT3.\",\n      \"method\": \"Immunoblot and immunocytochemistry with subtype-specific antibodies; electron microscopy\",\n      \"journal\": \"Brain research. Molecular brain research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — electron microscopic ultrastructural localization replicated across multiple brain regions and species by independent labs\",\n      \"pmids\": [\"8738166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TRPA1 channel-mediated Ca2+ influx in astrocytes regulates GABA transport by GAT-3. Decreased astrocyte resting Ca2+ caused by TRPA1 inhibition reduces GABA transport by GAT-3, elevating extracellular GABA and reducing inhibitory synapse efficacy in hippocampal interneurons. Thus, TRPA1-generated Ca2+ microdomains near the plasma membrane target GAT-3 function in astrocytes.\",\n      \"method\": \"Membrane-tethered genetically encoded calcium indicator (Lck-GCaMP3) imaging; pharmacological blockade of TRPA1 and GAT-3 (SNAP-5114); electrophysiology in brain slices\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (Ca2+ imaging, pharmacology, electrophysiology) in both cultures and brain slices establishing Ca2+-GAT-3 mechanistic link\",\n      \"pmids\": [\"22158513\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In wild-type mouse striatum, GAT-3 operates in a releasing (reverse transport) mode, contributing to tonic GABAA receptor-mediated inhibition in striatal output neurons. In Huntington's disease mouse models (Z_Q175_KI and R6/2), this non-synaptic GABA release through GAT-3 is lost, reducing tonic inhibition. Astrocyte depolarization facilitates GABA release via GAT-3.\",\n      \"method\": \"Whole-cell patch-clamp recordings in acute brain slices; pharmacological blockade of GAT-3 with SNAP-5114; TTX application to separate synaptic from non-synaptic components\",\n      \"journal\": \"Frontiers in neural circuits\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — electrophysiology with selective GAT-3 blocker in multiple HD mouse models; single lab, two HD models support the finding\",\n      \"pmids\": [\"24324407\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In dopamine-depleted Parkinsonian rodents, glial GAT-3 transporters are downregulated in the external globus pallidus while neuronal GAT-1 function remains normal, leading to elevated extracellular GABA and persistent GABAergic tonic inhibition in GP neurons. In vivo GAT-3 blockade in control rodents impairs motor coordination, directly linking GAT-3 to basal ganglia motor control.\",\n      \"method\": \"Western blot for GAT-3 protein; whole-cell patch-clamp in brain slices; in vivo pharmacological blockade; dopamine depletion rodent models\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (Western blot, electrophysiology, in vivo behavior) in single lab using established PD models\",\n      \"pmids\": [\"29742425\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Neuroinflammation induced by hyperammonemia increases membrane expression of GAT-3 in activated astrocytes of the cerebellum, which increases extracellular GABA and impairs motor coordination and learning. Sulforaphane, by promoting M2 microglial polarization, reduces astrocyte activation and normalizes GAT-3 membrane expression and extracellular GABA levels.\",\n      \"method\": \"Western blot for GAT-3 membrane expression; immunohistochemistry; microdialysis for extracellular GABA; behavioral testing (Y maze, beam walking); sulforaphane treatment in hyperammonemic rats\",\n      \"journal\": \"Journal of neuroinflammation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (Western blot, microdialysis, behavior) in a single lab; neuroinflammation-GAT-3 membrane trafficking link established\",\n      \"pmids\": [\"27090509\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Down-regulation of GAT-3 in thalamic astrocytes is sufficient to produce cellular and circuit hyperexcitability, enhanced seizure risk, and cortical rhythm disruptions similar to those seen after cortical injury in mice. Enhancing GAT-3 expression specifically in thalamic astrocytes prevented these deficits and was protective against chemoconvulsant-induced seizures and mortality in a traumatic brain injury model.\",\n      \"method\": \"Viral vector-mediated GAT-3 knockdown and overexpression in thalamic astrocytes; EEG recording; seizure threshold testing; mouse models of cortical injury and TBI\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — bidirectional genetic manipulation (knockdown and rescue) in astrocyte-specific manner with multiple circuit and behavioral readouts in vivo; multiple injury models\",\n      \"pmids\": [\"35857628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"GAT-3 transporter blockade with SNAP-5114 in rat neocortical slices increases the amplitude of evoked GABAA responses and increases frequency and amplitude of spontaneous IPSCs in an action potential-dependent manner. This demonstrates that GAT-3 normally reduces ambient GABA levels, possibly by mediating carrier-mediated GABA release, and regulates inhibitory interneuron output.\",\n      \"method\": \"In vitro neocortical slice electrophysiology; pharmacological blockade of GAT-3 with SNAP-5114; TTX to test action potential dependence\",\n      \"journal\": \"Journal of neurophysiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — selective pharmacology with TTX controls establishing action potential-dependent mechanism; single lab\",\n      \"pmids\": [\"16135550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In the rat globus pallidus, GAT-1 is localized preferentially to unmyelinated axons while GAT-3 is almost exclusively in glial processes. GAT-3 blockade (SNAP-5114) increases amplitude and prolongs decay time of evoked IPSCs from striatal stimulation, while GAT-1 blockade prolongs decay time only. Combined blockade has additive effects. High concentrations of both blockers induce GABAA receptor-mediated tonic currents, demonstrating complementary roles of the two transporters in regulating phasic and tonic inhibition.\",\n      \"method\": \"Electron microscopic immunocytochemistry; whole-cell patch-clamp in GP slices; pharmacological blockade with SKF89976A (GAT-1) and SNAP-5114 (GAT-3)\",\n      \"journal\": \"The European journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ultrastructural localization combined with functional electrophysiology with selective blockers; single lab\",\n      \"pmids\": [\"21410779\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In the ventral pallidum, GAT-3 is upregulated in astrocytes during extinction of heroin seeking but not after mere withdrawal or extinction of sucrose seeking. Knockdown of GAT-3 with a vivo-morpholino restored heroin seeking in the extinguished context and disrupted extinction. This establishes that astrocytic GAT-3 upregulation is a necessary mechanism for extinction of drug seeking.\",\n      \"method\": \"Confocal microscopy with membrane-bound fluorescent labeling of astrocytes; Western blot for GAT-3; vivo-morpholino knockdown; heroin self-administration and extinction behavioral paradigm\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function knockdown with specific behavioral readout (heroin seeking) combined with expression quantification; single lab\",\n      \"pmids\": [\"34642457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Glutamate activates ionotropic glutamate receptors on avian Müller glial cells to decrease GAT-3 plasma membrane levels (shown by surface biotinylation), reducing GABA uptake capacity by ~50%. This effect is not mediated by PKC or PKA signaling pathways. Conditioned media from retinal neurons also decreases GABA uptake in a glutamate receptor-dependent manner.\",\n      \"method\": \"Surface biotinylation assay; [3H]GABA uptake assay; pharmacological receptor blockade; conditioned media experiments\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — surface biotinylation directly demonstrates membrane trafficking of GAT-3 regulated by glutamate receptor signaling; two complementary methods\",\n      \"pmids\": [\"25700791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GAT3 protein levels are decreased in peri-infarct tissue from 6 hours to 42 days post-stroke in mice. The GAT3 substrate L-isoserine, administered into the infarct, increased GAT3 expression in peri-infarct regions and improved motor recovery in a concentration-dependent manner without affecting infarct volume, demonstrating that a GAT3 substrate can upregulate GAT3 surface expression as a substrate-induced trafficking mechanism.\",\n      \"method\": \"Photothrombotic stroke mouse model; Western blot for GAT3 protein; intracranial L-isoserine infusion; behavioral assessment (grid-walking, cylinder tasks); immunohistochemistry\",\n      \"journal\": \"Journal of cerebral blood flow and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Western blot expression plus in vivo functional rescue experiment; single lab; substrate-induced trafficking mechanism proposed and supported by behavioral outcomes\",\n      \"pmids\": [\"29160736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Activation of GAT-3 in dentate gyrus astrocytes triggers an increase in intracellular Ca2+ via the reverse Na+/Ca2+ exchanger. GAT-3 inhibition (SNAP-5114) impedes GABA-induced elevation of astrocytic Ca2+, curtailing subsequent enhancement of synaptic transmission. Endogenously released GABA from interneurons modulates synaptic transmission through GAT-3, and GAT-3 enhances excitatory transmission via presynaptic GluN2B-containing NMDARs. In vivo GAT-3 inhibition impairs contextual fear memory consolidation.\",\n      \"method\": \"Whole-cell patch-clamp; optogenetics; immunohistochemistry; behavioral assays (contextual fear conditioning); Ca2+ chelation experiments\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (electrophysiology, optogenetics, behavior) in single lab establishing Ca2+-dependent GAT-3 signaling mechanism\",\n      \"pmids\": [\"39573851\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In developing somatosensory cortex of GAD67-GFP haplodeficient mice, GAT-3 operates in reverse (releasing) mode to provide ambient GABA for tonic activation of presynaptic and postsynaptic GABA-B receptors, restricting neuronal excitability. Blockade of GAT-3 (SNAP-5114) reproduced the effects of GABA-B receptor blockade (CGP55845), demonstrating that GAT-3-mediated reverse transport is the primary source of ambient GABA activating GABA-B receptors in this context.\",\n      \"method\": \"Whole-cell patch-clamp in cortical slices (P14-P21); multi-electrode array recordings; pharmacological blockade of GAT-3 and GABA-B receptors\",\n      \"journal\": \"Frontiers in synaptic neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — electrophysiology with pharmacological tools; GABA-B blockade mimicked by GAT-3 blockade; single lab\",\n      \"pmids\": [\"37325697\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Haploinsufficiency of SLC6A11 (GAT3), as modeled in HEK293T cells, results in reduced GAT3 protein expression and reduced GABA uptake, comparable in magnitude to known SLC6A1 missense variants. This establishes that one functional allele of SLC6A11 is insufficient for normal GABA transport capacity. 4-phenylbutyrate (PBA) treatment improved GABA uptake in haploinsufficient models and reduced epileptiform discharges in patients.\",\n      \"method\": \"[3H]GABA uptake assays in HEK293T cells; Western blotting; EEG recordings in patients; clinical phenotyping\",\n      \"journal\": \"Epilepsy research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct functional assay (GABA uptake) and Western blot in cell model plus patient EEG; single study combining cell and clinical data\",\n      \"pmids\": [\"39923323\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Proteochemometric modeling identified amino acid Q299 (in GAT3, corresponding to L300/Q299/L294/L314 in GAT1/BGT1/GAT2/GAT3) as a key residue for ligand binding and subtype selectivity of GAT3 relative to the other GABA transporter subtypes.\",\n      \"method\": \"Proteochemometric modeling (partial least squares, random forest) using dataset of 323 compounds with bioactivity data across four GABA transporter subtypes; analysis of protein descriptor importance\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — computational prediction only, no experimental mutagenesis or structural validation of Q299 role performed in this study\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Functionally validated SLC6A11 variants (identified in patients with genetic generalized epilepsy) show reduced GAT3 GABA uptake activity, and the degree of activity reduction is linked to epilepsy severity, establishing a quantitative loss-of-function mechanism for SLC6A11 variants in epilepsy.\",\n      \"method\": \"Functional GAT3 uptake assays for SLC6A11 variants; cohort screening of 708 epilepsy patients; correlation of functional activity with clinical severity\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct functional uptake assays for multiple variants in patient cohort; preprint, single study\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Genetic ablation of GAT-3 (Gat3 CRISPR knockout) in astrocytes of the mouse visual cortex increases spontaneous and visually driven neuronal response magnitudes and trial-to-trial variability, and impairs population-level stimulus encoding, demonstrating that astrocytic GAT-3-mediated GABA clearance is required for accurate sensory information encoding.\",\n      \"method\": \"Multiplexed CRISPR/Cas9 Gat3 knockout in mouse visual cortex; in vivo two-photon calcium imaging; population neuronal response analysis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo genetic loss-of-function with defined circuit readout; preprint, single lab\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"GAT-3 inhibition with SNAP-5114 in the dorsal hippocampus impairs spatial memory consolidation (but not acquisition) and memory expression. This consolidation deficit is associated with reduced hippocampal protein synthesis (confirmed by puromycin incorporation assay). The memory deficit is rescued by prior open field exposure or proteasome inhibition but not by broader GABA transporter inhibition (nipecotic acid did not affect reconsolidation in the same way), indicating GAT-3 specifically modulates consolidation through protein synthesis mechanisms.\",\n      \"method\": \"Pharmacological GAT-3 inhibition (SNAP-5114) by stereotaxic injection; spatial object recognition task; puromycin incorporation assay for protein synthesis; behavioral rescue experiments\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct in vivo GAT-3 blockade with protein synthesis assay linking GAT-3 function to consolidation mechanism; single lab; published 2026\",\n      \"pmids\": [\"42086667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In a C6 glioma model, GAT3 interacts with PMCA4 Ca2+ transporter and calmodulin within lipid raft microdomains. GAT3 knockdown alters resting Ca2+ and Ca2+ accumulation in lipid rafts following GABA stimulation, impairing glioma cell migration and invasion. Long-term GABA stimulation disrupts the PMCA4/GAT3 complex and induces GAT3- and CaMKII-dependent CREB phosphorylation at Ser133, controlling glioma invasiveness.\",\n      \"method\": \"Co-immunoprecipitation; lipid raft fractionation; Ca2+ imaging; GAT3 knockdown; glioma migration/invasion assays; Western blot for pCREB\",\n      \"journal\": \"Cell calcium\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP/pulldown in glioma cell model; single lab; functional linkage to CaMKII/CREB is mechanistically novel but based on single study with limited validation\",\n      \"pmids\": [\"40580687\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SLC6A11/GAT3 is an astrocyte-localized, Na+- and Cl--dependent high-affinity GABA transporter (requiring >1 Na+ per cycle) whose C-terminal THF motif mediates PDZ-dependent apical membrane targeting; cryo-EM structures reveal substrate GABA bound in an inward-occluded state via a cation-π interaction with TM6 phenylalanine and selective inhibitors trapped in an inward-open state within the intracellular permeation pathway; beyond canonical GABA reuptake, GAT3 can operate in reverse (releasing) mode to provide ambient GABA for tonic GABA-B/GABA-A receptor activation, and its membrane expression is dynamically regulated by astrocyte Ca2+ (via TRPA1), neuroinflammation, and glutamate receptor signaling, with thalamic and pallidal astrocytic GAT3 activity being required for normal circuit excitability, motor control, memory consolidation, and protection against seizures after brain injury.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SLC6A11 (GAT3) is an astrocyte-localized, Na+- and Cl--dependent high-affinity GABA transporter that mediates glial GABA clearance and thereby sets ambient GABA tone to control neural circuit excitability [#1, #4, #5]. Transport requires more than one Na+ ion per cycle (sigmoidal Na+ dependence, Hill coefficient ~1.65) and a Cl- co-substrate whose binding precedes GABA recognition, and the transporter is pharmacologically distinguished from other GABA transporter subtypes by the selective inhibitor (S)-SNAP-5114 [#1, #2]. Cryo-EM structures of the full-length human protein captured inhibitor-bound (inward-open), GABA-bound (inward-occluded), and substrate-free states, defining the ion-coordination network, a cation-\\u03c0 interaction between GABA's \\u03b3-amino group and a TM6 phenylalanine, and an intracellular inhibitor-binding pocket lined by TM1, 2, 3, 6, 7, and 8 [#0]. Surface delivery is directed by the C-terminal cytoplasmic tail, whose terminal THF motif mediates PDZ-dependent apical targeting [#3]. GAT3 membrane abundance is dynamically regulated: astrocyte Ca2+ entering through TRPA1 channels supports transport activity, while glutamate-receptor signaling, neuroinflammation, and substrate exposure adjust surface levels [#6, #14, #9, #15]. Beyond reuptake, GAT3 can run in reverse to release GABA that drives tonic GABA-A and GABA-B receptor activation [#7, #17, #11]. Astrocytic GAT3 activity in the thalamus, pallidum, hippocampus, and cortex is required for normal circuit excitability, motor control, sensory encoding, and memory consolidation, and its enhancement protects against seizures after brain injury [#10, #8, #16, #22]. Functionally validated loss-of-function SLC6A11 variants and haploinsufficiency reduce GABA uptake and cause genetic generalized epilepsy [#18, #20].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Establishing GAT3 as a functional, ion-coupled GABA transporter answered what activity the cloned gene product performs and how its transport cycle is energized.\",\n      \"evidence\": \"Heterologous expression in LLC-PK1 cells with radiolabeled GABA uptake, ion-substitution, and kinetic analysis\",\n      \"pmids\": [\"7935337\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry inferred from Hill coefficients rather than direct ion flux measurement\", \"Did not address native cellular context or trafficking\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Identifying (S)-SNAP-5114 as a GAT3-preferring inhibitor distinguished GAT3 pharmacologically from GAT1, GAT2, and BGT1, providing the tool used in nearly all subsequent functional dissection.\",\n      \"evidence\": \"Molecular cloning, heterologous expression, and competitive uptake inhibition across four GABA transporter subtypes\",\n      \"pmids\": [\"7874447\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of subtype selectivity not resolved\", \"Did not define inhibitor binding site\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Ultrastructural localization established that GAT3, unlike neuronal GAT1, resides in astrocytic processes, defining it as the glial arm of GABA uptake.\",\n      \"evidence\": \"Dual-label immunogold electron microscopy in rat cortex and cerebellum with subtype-specific antibodies\",\n      \"pmids\": [\"8815906\", \"8738166\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish functional consequence of glial localization\", \"Mechanism restricting GABA spread inferred from anatomy\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Mapping the apical-sorting signal to the C-terminal THF motif explained how GAT3 is targeted to a specific membrane domain and implicated a PDZ-domain partner.\",\n      \"evidence\": \"Deletion and chimeric GAT2/GAT3 constructs in polarized MDCK cells with immunofluorescence localization\",\n      \"pmids\": [\"9748227\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The specific PDZ-domain protein was not identified\", \"Sorting studied in epithelial, not astrocytic, cells\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Showing that GAT3 blockade increases ambient GABA and IPSCs established that GAT3 actively limits extracellular GABA and shapes inhibitory output.\",\n      \"evidence\": \"Neocortical slice electrophysiology with SNAP-5114 and TTX action-potential controls\",\n      \"pmids\": [\"16135550\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not distinguish uptake vs. carrier-mediated release directly\", \"Single brain region, single lab\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Linking astrocyte TRPA1-mediated Ca2+ microdomains to GAT3 function revealed that transport is dynamically gated by local astrocytic calcium.\",\n      \"evidence\": \"Membrane-tethered GCaMP3 imaging, TRPA1/GAT3 pharmacology, and slice electrophysiology\",\n      \"pmids\": [\"22158513\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular coupling between Ca2+ and transporter activity unresolved\", \"Whether Ca2+ alters trafficking or intrinsic transport rate not separated\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrating complementary phasic/tonic roles of glial GAT3 and axonal GAT1 in globus pallidus clarified the division of labor between the two transporters.\",\n      \"evidence\": \"Electron microscopic immunocytochemistry plus patch-clamp with selective GAT1/GAT3 blockers\",\n      \"pmids\": [\"21410779\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Additive vs. interactive effects only inferred pharmacologically\", \"Single lab\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identifying a reverse (releasing) mode of GAT3 contributing to tonic inhibition, lost in Huntington's models, extended GAT3's role beyond reuptake to active GABA supply.\",\n      \"evidence\": \"Patch-clamp in striatal slices with SNAP-5114 and TTX in two HD mouse models\",\n      \"pmids\": [\"24324407\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Trigger and directionality control of reverse transport not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showing glutamate-receptor signaling reduces GAT3 surface levels identified neurotransmitter-driven trafficking as a regulator of glial GABA uptake capacity.\",\n      \"evidence\": \"Surface biotinylation and [3H]GABA uptake with receptor blockade in avian Muller glia\",\n      \"pmids\": [\"25700791\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Signaling pathway downstream of glutamate receptors unknown (not PKC/PKA)\", \"Avian retinal glia model\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrating that neuroinflammation increases GAT3 membrane expression and elevates extracellular GABA tied transporter trafficking to disease-relevant behavioral deficits.\",\n      \"evidence\": \"Membrane Western blot, microdialysis, and behavior in hyperammonemic rats with sulforaphane rescue\",\n      \"pmids\": [\"27090509\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct astrocyte signaling mediating increased surface GAT3 not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showing a GAT3 substrate (L-isoserine) can upregulate GAT3 and improve post-stroke recovery established substrate-induced trafficking as a tractable mechanism.\",\n      \"evidence\": \"Photothrombotic stroke model, Western blot, intracranial substrate infusion, and motor behavior\",\n      \"pmids\": [\"29160736\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Trafficking mechanism inferred from expression changes, not directly imaged\", \"Single lab\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Linking pallidal GAT3 downregulation to elevated GABA tone and motor impairment in Parkinsonian models connected GAT3 directly to basal ganglia motor control.\",\n      \"evidence\": \"Western blot, slice patch-clamp, and in vivo GAT3 blockade in dopamine-depleted rodents\",\n      \"pmids\": [\"29742425\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cause of GAT3 downregulation after dopamine depletion unknown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Bidirectional astrocyte-specific manipulation showed thalamic GAT3 level is causally sufficient to set circuit excitability and seizure risk, nominating it as a therapeutic target.\",\n      \"evidence\": \"Viral GAT3 knockdown/overexpression in thalamic astrocytes with EEG and seizure assays in injury models\",\n      \"pmids\": [\"35857628\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether thalamic mechanism generalizes to other epileptogenic circuits unclear\", \"Downstream receptor targets of altered GABA tone not mapped here\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identifying GAT3-driven Ca2+ entry via reverse Na+/Ca2+ exchange and its requirement for fear memory consolidation revealed a signaling output of GAT3 beyond GABA clearance.\",\n      \"evidence\": \"Patch-clamp, optogenetics, Ca2+ chelation, and contextual fear conditioning in dentate gyrus\",\n      \"pmids\": [\"39573851\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Link between astrocytic Ca2+ and presynaptic GluN2B-NMDAR enhancement mechanistically incomplete\", \"Single lab\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Showing GAT3 reverse transport is the primary source of ambient GABA activating GABA-B receptors in developing cortex defined a developmental excitability-restraining role.\",\n      \"evidence\": \"Cortical slice patch-clamp and multi-electrode arrays with GAT3 and GABA-B blockade in GAD67-GFP mice\",\n      \"pmids\": [\"37325697\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Developmental specificity vs. adult function not addressed\", \"Single lab\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Functional analysis of patient variants and modeled haploinsufficiency established a quantitative loss-of-function mechanism connecting reduced GAT3 GABA uptake to genetic generalized epilepsy.\",\n      \"evidence\": \"GABA uptake assays for SLC6A11 variants in HEK293T cells, cohort screening, EEG, and 4-PBA rescue\",\n      \"pmids\": [\"39923323\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal proof in vivo from patient variants not yet shown\", \"Genotype-phenotype severity correlation from preprint cohort (PMID-less) needs peer review\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Cryo-EM of full-length human GAT3 in multiple states defined the atomic basis of GABA recognition, ion coordination, and inhibitor selectivity, anchoring decades of functional pharmacology to structure.\",\n      \"evidence\": \"Cryo-EM structures of wild-type human GAT3 bound to inhibitor, GABA, and substrate-free\",\n      \"pmids\": [\"41611703\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Outward-facing and fully outward-open states not captured\", \"Conformational dynamics of transport cycle inferred from static states\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Showing hippocampal GAT3 inhibition selectively impairs memory consolidation via reduced protein synthesis distinguished a consolidation-specific role from general GABA transport.\",\n      \"evidence\": \"Stereotaxic SNAP-5114 injection, spatial object recognition, puromycin incorporation, and rescue experiments\",\n      \"pmids\": [\"42086667\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular path from GAT3 activity to protein synthesis not delineated\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How GAT3 surface trafficking, reverse-transport directionality, and astrocytic Ca2+ signaling are molecularly coordinated across circuits, and the identity of its PDZ-domain sorting partner, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"PDZ partner mediating THF-dependent targeting not identified\", \"Mechanism switching uptake vs. release mode undefined\", \"Direct in vivo causation for human epilepsy variants outstanding\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [1, 2, 0, 18]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [1, 7, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 4, 5, 14]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [4, 11, 10, 16]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}